These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27503549)

  • 1. Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system.
    Loganathan T; Jit M; Hutubessy R; Ng CW; Lee WS; Verguet S
    Trop Med Int Health; 2016 Nov; 21(11):1458-1467. PubMed ID: 27503549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
    Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
    Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catastrophic healthcare expenditure and poverty related to out-of-pocket payments for healthcare in Bangladesh-an estimation of financial risk protection of universal health coverage.
    Khan JAM; Ahmed S; Evans TG
    Health Policy Plan; 2017 Oct; 32(8):1102-1110. PubMed ID: 28575415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
    Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Household catastrophic healthcare expenditure and impoverishment due to rotavirus gastroenteritis requiring hospitalization in Malaysia.
    Loganathan T; Lee WS; Lee KF; Jit M; Ng CW
    PLoS One; 2015; 10(5):e0125878. PubMed ID: 25941805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
    Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
    Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
    Bruijning-Verhagen P; van Dongen JAP; Verberk JDM; Pijnacker R; van Gaalen RD; Klinkenberg D; de Melker HE; Mangen MJ
    BMC Med; 2018 Sep; 16(1):168. PubMed ID: 30196794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving equity in the distribution and financing of health services in Mauritius, a small island state with deeply rooted welfare state standards.
    Nundoochan A
    BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34952858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness estimates of vaccination against rotavirus in Piedmont, Italy.
    Gualano MR; Thomas R; Gili R; Scaioli G; Voglino G; Zotti C
    J Infect Public Health; 2018; 11(6):867-872. PubMed ID: 30078657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health gains and financial risk protection: an extended cost-effectiveness analysis of treatment and prevention of diarrhoea in Ethiopia.
    Pecenka CJ; Johansson KA; Memirie ST; Jamison DT; Verguet S
    BMJ Open; 2015 May; 5(4):e006402. PubMed ID: 25941175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic analysis of rotavirus vaccination in Italy.
    Giammanco MD; Coniglio MA; Pignato S; Giammanco G
    Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
    Patel HD; Roberts ET; Constenla DO
    Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia.
    Loganathan T; Ng CW; Lee WS; Hutubessy RCW; Verguet S; Jit M
    Health Policy Plan; 2018 Mar; 33(2):204-214. PubMed ID: 29228339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who benefits most from extending financial protection for cataract surgery in Vietnam? An extended cost-effectiveness analysis of small incision surgery.
    Essue BM; Jan S; Phuc HT; Dodson S; Armstrong K; Laba TL
    Health Policy Plan; 2020 May; 35(4):399-407. PubMed ID: 32031615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
    Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
    Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.